Redeye remains positive to Hanza following a better than expected Q2-report. While the Corona crisis has delayed Hanza’s progress in the short term, we still expect increasing margins going forward, and the crisis could very well help long-term growth. We increase our Base Case slightly to SEK 18 (17).

Read more and download the Research Update

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/

Attachments

Hanza Holding – Handles a Challenging Period

© Modular Finance, source Nordic Press Releases